AP1967A - Thiazolidinone compounds as inhibitors of Hyak3 - Google Patents

Thiazolidinone compounds as inhibitors of Hyak3

Info

Publication number
AP1967A
AP1967A AP2005003304A AP2005003304A AP1967A AP 1967 A AP1967 A AP 1967A AP 2005003304 A AP2005003304 A AP 2005003304A AP 2005003304 A AP2005003304 A AP 2005003304A AP 1967 A AP1967 A AP 1967A
Authority
AP
ARIPO
Prior art keywords
hyak3
inhibitors
thiazolidinone compounds
thiazolidinone
compounds
Prior art date
Application number
AP2005003304A
Other languages
English (en)
Other versions
AP2005003304A0 (en
Inventor
Masaichi Hasegawa
Jun Tang
Hideyuki Sato
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AP2005003304A0 publication Critical patent/AP2005003304A0/xx
Application granted granted Critical
Publication of AP1967A publication Critical patent/AP1967A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2005003304A 2002-11-22 2003-11-18 Thiazolidinone compounds as inhibitors of Hyak3 AP1967A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42838402P 2002-11-22 2002-11-22
PCT/US2003/037658 WO2004047760A2 (en) 2002-11-22 2003-11-18 Novel chemical compounds

Publications (2)

Publication Number Publication Date
AP2005003304A0 AP2005003304A0 (en) 2005-06-30
AP1967A true AP1967A (en) 2009-03-10

Family

ID=32393394

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003304A AP1967A (en) 2002-11-22 2003-11-18 Thiazolidinone compounds as inhibitors of Hyak3

Country Status (30)

Country Link
US (1) US7767701B2 (is)
EP (1) EP1567112B1 (is)
JP (1) JP2006509765A (is)
KR (1) KR20050085115A (is)
CN (1) CN100579978C (is)
AP (1) AP1967A (is)
AR (1) AR045407A1 (is)
AT (1) ATE411302T1 (is)
AU (1) AU2003298693B2 (is)
BR (1) BR0316502A (is)
CA (1) CA2507256A1 (is)
CY (1) CY1108655T1 (is)
DE (1) DE60324178D1 (is)
DK (1) DK1567112T3 (is)
EA (1) EA008865B1 (is)
EC (1) ECSP055808A (is)
ES (1) ES2315566T3 (is)
IS (1) IS2659B (is)
MA (1) MA27701A1 (is)
MX (1) MXPA05005406A (is)
MY (1) MY140132A (is)
NO (1) NO20052928L (is)
NZ (1) NZ539873A (is)
OA (1) OA12963A (is)
PL (1) PL377564A1 (is)
PT (1) PT1567112E (is)
SI (1) SI1567112T1 (is)
TW (1) TWI309648B (is)
UA (1) UA80572C2 (is)
WO (1) WO2004047760A2 (is)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100669578B1 (ko) 2002-01-22 2007-01-15 워너-램버트 캄파니 엘엘씨 2-(피리딘-2-일아미노)-피리도[2,3-ｄ]피리미딘-7-온
CN1835951B (zh) * 2003-07-11 2010-06-02 沃尼尔·朗伯有限责任公司 选择性cdk4抑制剂的羟乙基磺酸盐
CA2531140C (en) * 2003-07-28 2013-06-18 Applied Research Systems Ars Holding N.V. 2-imino-4-(thio) oxo-5-polycyclovinylazolines for use as pi3 kinase inhibitors
AU2004295047B2 (en) 2003-11-21 2011-03-10 Laboratoires Juvise Pharmaceuticals 5-(benz- (Z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
USRE43833E1 (en) 2003-11-21 2012-11-27 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
EP1718642A4 (en) * 2004-02-25 2010-11-24 Glaxosmithkline Llc NEW CHEMICAL COMPOUNDS
PE20060373A1 (es) 2004-06-24 2006-04-29 Smithkline Beecham Corp Derivados 3-piperidinil-7-carboxamida-indazol como inhibidores de la actividad cinasa de ikk2
RU2007103709A (ru) * 2004-07-01 2008-08-10 Ф.Хоффманн-Ля Рош Аг (Ch) Тиазолинонхинолины
MXPA06015026A (es) * 2004-07-01 2007-02-08 Hoffmann La Roche Nuevas quinolinas de tiazolinonas con actividad antiproliferante de las cinasas dependientes de ciclina 1 (cdk1).
US7253285B2 (en) * 2004-09-17 2007-08-07 Hoffmann-La Roche Inc. Thiazolinone 4-monosubstituted quinolines
US7241893B2 (en) * 2004-09-17 2007-07-10 Hoffman-La Roche Inc. Thiazolinone 2-substituted quinolines
EP1807075A2 (en) * 2004-10-12 2007-07-18 Applied Research Systems ARS Holding N.V. Pi3 kinase gamma inhibitors for the treatment of anaemia
EP1805175B1 (en) * 2004-10-14 2008-03-05 F. Hoffmann-Roche AG Novel azaindole thiazolinones as anti-cancer agents
CA2583192A1 (en) * 2004-10-14 2006-04-20 F. Hoffmann-La Roche Ag 1,5-naphthyridine azolidinones having cdk1 antiproliferative activity
JP2008516904A (ja) * 2004-10-14 2008-05-22 エフ．ホフマン−ラ ロシュ アーゲー Ｃｄｋ１阻害剤としてのキナゾリニルメチレンチアゾリノン
US7304074B2 (en) 2005-04-05 2007-12-04 Hoffmann-La Roche Inc. Substituted 1,5-naphthyridine azolinones
AR053602A1 (es) * 2005-05-03 2007-05-09 Smithkline Beecham Corp Compuesto de 2- arilamino -4-oxo-1,3-tiazol-5(4h)- substituido, composicion farmaceutica que lo comprende, proceso para prepararla y uso del compuesto para preparar un medicamento
EP1885362A4 (en) * 2005-05-23 2010-09-22 Glaxosmithkline Llc NEW CHEMICAL COMPOUNDS
PE20070083A1 (es) * 2005-06-08 2007-01-27 Smithkline Beecham Corp (5z)-5-(6-quinoxalinilmetilideno)-2-[(2,6-diclorofenil)amino]-1,3-tiazol-4(5h)-ona
EP1888557A4 (en) * 2005-06-08 2012-02-15 Glaxosmithkline Llc (5Z) -5- (6-QUINOXALINYLMETHYLIDENE) -2-Ý (2,4,6-trichlorophenyl) amino-1,3-thiazol-4 (5H) -one
TW200745066A (en) 2005-09-16 2007-12-16 Torrent Pharmaceuticals Ltd Novel PTP1B inhibitors
EP1954136A4 (en) * 2005-11-08 2011-01-05 Glaxosmithkline Llc NEW CHEMICAL COMPOUNDS
WO2007103754A2 (en) * 2006-03-02 2007-09-13 Smithkline Beecham Corporation Thiazolones for use as pi3 kinase inhibitors
EP1993538A4 (en) * 2006-03-02 2010-05-19 Glaxosmithkline Llc THIAZOLONES AS INHIBITORS OF P13-KINASES
KR100752757B1 (ko) * 2006-04-05 2007-08-29 한국과학기술연구원 2-페닐이미노-1,3-티아졸린을 포함하는 미백 조성물
EP2016062A2 (en) * 2006-04-25 2009-01-21 The Cleveland Clinic Foundation Anti-viral agents that activate rnase l
US8912340B2 (en) 2006-11-23 2014-12-16 Actelion Pharmaceuticals Ltd. Process for the preparation of 2-imino-thiazolidin-4-one derivatives
DK2094676T3 (da) * 2006-11-23 2013-06-10 Actelion Pharmaceuticals Ltd Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater
US20100286041A1 (en) * 2007-03-22 2010-11-11 Smithkline Beecham Corporation (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one
CN101274918A (zh) * 2007-03-30 2008-10-01 中国科学院上海药物研究所 一类取代五元杂环化合物,其制备方法和医学用途
EP2423204A4 (en) 2009-04-20 2013-01-09 Sbi Biotech Co Ltd THIAZOLIDINONDERIVAT
CA3006139C (en) 2012-07-30 2020-06-02 Kyoto University Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor
CN104540800B (zh) 2012-08-17 2017-05-10 埃科特莱茵药品有限公司 制备(2z,5z)‑5‑(3‑氯‑4‑((r)‑2,3‑二羟基丙氧基)苯亚甲基)‑2‑(丙亚氨基)‑3‑(邻甲苯基)噻唑烷‑4‑酮的方法及在该方法中所用的中间产物
RU2521390C1 (ru) * 2013-03-14 2014-06-27 Общество с ограниченной ответственностью "Тиацен" Производное роданина и средство для профилактики опухолевых заболеваний
HRP20220490T8 (hr) * 2014-05-28 2022-06-10 Universität Bern Spojevi tiazolidinona i njihova upotreba u liječenju psihijatrijskih ili neuroloških poremećaja i inflamacije, posebno neuroinflamacije
CN104370852B (zh) * 2014-11-26 2016-04-20 山东大学 一种噻唑烷酮类化合物及其在制备治疗铁紊乱相关疾病药物中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1604530A (is) * 1967-06-06 1971-11-29

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545648A (en) 1978-09-29 1980-03-31 Teikoku Hormone Mfg Co Ltd 2-formyldibenzazepin derivative and its preparation
HU188852B (en) * 1983-03-16 1986-05-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
SU1611216A3 (ru) * 1986-12-29 1990-11-30 Пфайзер Инк (Фирма) Способ получени производных тиазолидиндиона или их фармацевтически приемлемых солей с щелочными металлами
DE3874257T2 (de) 1987-03-11 1993-02-11 Kanegafuchi Chemical Ind Hydroxystyren-derivate.
JPH0197926A (ja) 1987-10-09 1989-04-17 Idemitsu Kosan Co Ltd 有機非線型光学材料
DD270072A1 (de) 1988-03-14 1989-07-19 Univ Halle Wittenberg Verfahren zur herstellung von 5-aryliden- hoch 2-thiazolin-4-onen
US5306822A (en) 1988-05-25 1994-04-26 Warner-Lambert Company Arylmethylenyl derivatives of oxazolidinone
US5145753A (en) 1989-09-12 1992-09-08 Mitsubishi Jukogyo Kabushiki Kaisha Solid electrolyte fuel cell
US5053420A (en) 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
GB9004483D0 (en) 1990-02-28 1990-04-25 Erba Carlo Spa New aryl-and heteroarylethenylene derivatives and process for their preparation
US5143928A (en) 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
JPH052200A (ja) 1990-09-28 1993-01-08 Toshiba Corp 有機非線形光学材料
ATE179615T1 (de) * 1991-02-08 1999-05-15 Pro Neuron Inc Oxypurin-nukleoside und seine artverwandten, und acylderivate davon, zur verbesserung der hämatopoese
JP3155050B2 (ja) 1991-02-28 2001-04-09 富士通株式会社 荷電粒子ビームを用いた露光方法
DE69318863T2 (de) 1992-02-03 1998-09-24 Fuji Photo Film Co Ltd Verfahren zur Dispergierung eines Farbstoffs und ein Farbstoff enthaltendes photographisches Silberhalogenidmaterial
JP2835246B2 (ja) 1992-06-02 1998-12-14 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
ZA936492B (en) 1992-09-10 1995-03-02 Lilly Co Eli Compounds useful as hypoglycemic agents and for treating Alzheimer's disease.
EP0587229B1 (en) 1992-09-11 2002-05-08 Agfa-Gevaert Photographic element containing a filter dye for rapid processing applications
EP0587230B1 (en) 1992-09-11 2003-11-26 Agfa-Gevaert Photographic element containing a filter dye for rapid processing applications
JPH06128234A (ja) 1992-10-19 1994-05-10 Fuji Photo Film Co Ltd 不斉炭素原子を有する化合物およびそれからなる非線形光学材料
US5554767A (en) 1993-05-21 1996-09-10 Warner-Lambert Company Alpha-mercaptoacrylic acid derivatives having calpain inhibitory activity
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
JP3871354B2 (ja) 1994-07-29 2007-01-24 株式会社フジモト・コーポレーション 新規な２−（ｎ−シアノイミノ）チアゾリジン−４−オン誘導体
JPH08109176A (ja) 1994-10-07 1996-04-30 Torii Yakuhin Kk イソローダニンｎ酢酸誘導体
IL117208A0 (en) 1995-02-23 1996-06-18 Nissan Chemical Ind Ltd Indole type thiazolidines
AU707537B2 (en) * 1995-07-31 1999-07-15 Anthera Pharmaceuticals, Inc. Pyrrolidine derivatives having phospholipase a2 inhibitory activity
US5618835A (en) 1996-02-01 1997-04-08 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
JPH09255669A (ja) 1996-03-22 1997-09-30 Hisamitsu Pharmaceut Co Inc 新規なベンジリデン誘導体
US5958957A (en) 1996-04-19 1999-09-28 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
UY24886A1 (es) 1997-02-18 2001-08-27 Smithkline Beecham Plc Tiazolidindiona
US6011031A (en) 1997-05-30 2000-01-04 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
US6211209B1 (en) * 1997-08-08 2001-04-03 Warner-Lambert Company Method of inhibiting connective tissue degradation
AU4005299A (en) 1998-05-19 1999-12-06 Regents Of The University Of California, The Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis
AU6330999A (en) 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
US6221613B1 (en) 1998-12-31 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
US6689491B1 (en) 1999-02-08 2004-02-10 Fuji Photo Film Co., Ltd. Luminescent device material, luminescent device using the same, and amine compound
US6372742B1 (en) 1999-07-01 2002-04-16 Geron Corporation Substituted indole compounds and methods of their use
JP2001348520A (ja) 2000-04-03 2001-12-18 Fuji Photo Film Co Ltd メチン化合物、固体微粒子分散物、インクジェット用記録液、およびインクジェット記録方法
CA2384041A1 (en) 2000-07-05 2002-01-24 Synaptic Pharmaceuticals Corporation Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
US6410734B1 (en) 2000-07-17 2002-06-25 Wyeth 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
DE10115227A1 (de) 2001-03-28 2002-12-19 Bayer Ag Optischer Datenträger enthaltend in der Informationsschicht eine lichtabsorbierende Verbindung mit mehreren chromophoren Zentren
US6452014B1 (en) 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
TW200304375A (en) * 2001-12-06 2003-10-01 Maxia Pharmaceuticals Inc 2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1604530A (is) * 1967-06-06 1971-11-29

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 68, no. 19, 1968, Columbus, Ohio, US; abstract no.: 87228f *

Also Published As

Publication number Publication date
EA200500856A1 (ru) 2005-10-27
DE60324178D1 (de) 2008-11-27
MY140132A (en) 2009-11-30
AU2003298693A1 (en) 2004-06-18
HK1083443A1 (en) 2006-07-07
US20060293338A1 (en) 2006-12-28
KR20050085115A (ko) 2005-08-29
ATE411302T1 (de) 2008-10-15
EP1567112B1 (en) 2008-10-15
PT1567112E (pt) 2009-01-08
MA27701A1 (fr) 2006-01-02
DK1567112T3 (da) 2009-02-09
ECSP055808A (es) 2005-09-20
EA008865B1 (ru) 2007-08-31
NO20052928D0 (no) 2005-06-15
EP1567112A4 (en) 2006-11-15
WO2004047760A3 (en) 2004-10-21
US7767701B2 (en) 2010-08-03
MXPA05005406A (es) 2005-08-03
CN1742010A (zh) 2006-03-01
NO20052928L (no) 2005-08-17
SI1567112T1 (sl) 2009-02-28
BR0316502A (pt) 2005-10-04
TW200418819A (en) 2004-10-01
JP2006509765A (ja) 2006-03-23
AR045407A1 (es) 2005-10-26
IS2659B (is) 2010-08-15
UA80572C2 (en) 2007-10-10
NZ539873A (en) 2008-09-26
WO2004047760A2 (en) 2004-06-10
OA12963A (en) 2006-10-13
CY1108655T1 (el) 2014-04-09
IS7879A (is) 2005-06-02
PL377564A1 (pl) 2006-02-06
AU2003298693B2 (en) 2010-09-30
AP2005003304A0 (en) 2005-06-30
CA2507256A1 (en) 2004-06-10
CN100579978C (zh) 2010-01-13
ES2315566T3 (es) 2009-04-01
EP1567112A2 (en) 2005-08-31
TWI309648B (en) 2009-05-11

Similar Documents

Publication Publication Date Title
AP1967A (en) Thiazolidinone compounds as inhibitors of Hyak3
PL372198A1 (en) Heteroaryl compounds useful as inhibitors of gsk-3
EP1549316A4 (en) HAMMER OF TFGbeta
GB2432159B (en) Intermediates for manufacturing peripherally-selective inhibitors of dopamine-beta-hydroxylase
AU2003261434A8 (en) Iminothiazolidinones as inhibitors of hcv replication
PL375389A1 (en) Novel inhibitors of kinases
IL169691A0 (en) Malonamide derivatives as gamma-secretase inhibitors
EP1551801A4 (en) NOVEL GAMMA-LACTAMES AS INHIBITORS OF BETA-SECRETASE
SI1497019T1 (sl) Pirolo-triazin anilin spojine uporabne kot inhibitorji kinaze
PL370478A1 (en) Aminoindazole derivatives as protein-kinase inhibitors
PT1562589E (pt) Diaminotriazoles úteis como inibidores de proteína-quinases
IL165887A0 (en) Novel tetrahydropyridine derivatives as renin inhibitors
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
IL175106A0 (en) Novel keto-oxadiazole derivatives as cathepsin inhibitors
PL378760A1 (pl) Pochodne oksazoli jako inhibitory cyklooksygenazy
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
IL164898A0 (en) Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
AU2003295638A8 (en) Novel inhibitors of beta-lactamase
EP1658274A4 (en) INHIBITORS OF CATHEPSIN S
AU2003300551A8 (en) Compounds for the inhibition of non-proteolytic enzymes
PT1656358E (pt) Polimorfo est?vel de mesilato de bifeprunox
EP1677782A4 (en) INHIBITORS OF CATHEPSIN S
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
PL1623977T3 (pl) Związek pośredni stosowany do wytwarzania pioglitazonu